MTT assays presented that PLK-4 silencing significantly reduced the viability of HCC cells while overexpression of PLK-4 abolished the suppressive effect of miR-126 on cell proliferation rate in HCC cells (Fig. 5g, h). Here, PLK4 is linked to hepatocellular carcinoma.